Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Kratom Delta8 Regulation topic
No spam. Unsubscribe anytime.
Northampton Board of Health hears hours of public comment on kratom and Delta‑8 as Belchertown-style ban draws attention
Summary
The Board of Health heard extensive public comment both for and against local restrictions on kratom and Delta‑8 after the Belchertown regulation drew national attention. Board members agreed not to adopt a regulation at the meeting and asked staff to gather more evidence and model language before any vote.
The Northampton City Board of Health held an extended discussion March 20 on local regulation of kratom and Delta‑8 products after a recently enacted Belchertown ordinance spurred public interest and testimony.
The board opened the topic for discussion after more than a dozen public commenters — many joining remotely from other states — spoke for and against local restrictions. Several speakers described personal benefits from kratom for chronic pain and recovery, while others, including bereaved parents, urged bans citing deaths they attribute to kratom.
Why it matters: the Board of Health is considering whether to ask staff to draft a local regulation modeled on Belchertown’s approach, to restrict sale to certain venues, or to pursue other limits. Any local action could affect convenience stores and specialty shops in Northampton and would come amid an uneven national regulatory landscape and conflicting scientific and advocacy claims.
Public testimony and positions - “The solution is to ban or is to regulate, not to ban,” said Laura Romney, who identified herself as a kratom advocate and educator (Layton, Utah) and urged the board to study regulated approaches such as age limits and product testing. - Jesse Bridger (Nashua, N.H.) and other consumers described kratom as a harm‑reduction tool and a substitute for prescription medications. - Multiple speakers, including Misty Brown and Amanda (Bedford, N.H.), described personal recovery stories and credited kratom with preventing relapse or reducing reliance on prescription opioids. - Testimony opposing kratom came from Holly (Dracut, Mass.) and Susan Eppert (Michigan). Eppert said her 22‑year‑old son died after using kratom powder and described an autopsy attributing his death to mitragynine. - Joseph Plant, a documentary filmmaker, warned of a pattern of federal and local grants and campaigns targeting kratom, and urged the board to examine funding and scientific sources cited by other municipalities.
Board discussion and next steps Board members and staff said they were not prepared to adopt a local regulation at the March meeting. Members asked staff to gather additional evidence and advice before a formal hearing: - The board asked staff to obtain model language and background from Cheryl Sabara (cited by multiple speakers as a drafter of the Belchertown regulation) and to compile materials from national scientific and public‑health organizations. - The board requested staff provide summaries of verified adverse‑event reports and peer‑reviewed studies, and to highlight distinctions between whole‑leaf kratom, concentrated extracts and synthetic alkaloids (for example, 7‑OH‑mitragynine). - Several board members signaled they would rely on clinical advice from clinicians on the board and from recognized addiction‑medicine bodies in reviewing the evidence.
No formal vote or regulation was adopted at the meeting. Board members said they wanted to see additional documentation — including whether and how other localities differentiate whole‑leaf products from extracts, how enforcement has worked in towns that adopted bans, and what the state or federal guidance would be — before scheduling a public hearing and vote.
Ending: The board directed staff to return with model language and a written summary of evidence to inform a future hearing. Members said they expect to consult with legal counsel and public‑health experts before considering any final action.
